These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2873862

  • 1. Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment.
    Bax DE, Greaves MS, Amos RS.
    Br J Rheumatol; 1986 Aug; 25(3):282-4. PubMed ID: 2873862
    [Abstract] [Full Text] [Related]

  • 2. Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.
    Pullar T, Hunter JA, Capell HA.
    Ann Rheum Dis; 1985 Dec; 44(12):831-7. PubMed ID: 2867746
    [Abstract] [Full Text] [Related]

  • 3. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T, Capell HA.
    Drugs; 1986 Dec; 32 Suppl 1():54-7. PubMed ID: 2877854
    [Abstract] [Full Text] [Related]

  • 4. Sulphasalazine for rheumatoid arthritis. Studies on dose, acetylator phenotype and efficacy.
    Amos RS, Bax DE, Greaves MS.
    Drugs; 1986 Dec; 32 Suppl 1():58. PubMed ID: 2877855
    [No Abstract] [Full Text] [Related]

  • 5. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1102-4. PubMed ID: 6138117
    [Abstract] [Full Text] [Related]

  • 6. Influence of acetylator status on sulphasalazine efficacy and toxicity in patients with rheumatoid arthritis.
    Kitas GD, Farr M, Waterhouse L, Bacon PA.
    Scand J Rheumatol; 1992 Oct 15; 21(5):220-5. PubMed ID: 1359635
    [Abstract] [Full Text] [Related]

  • 7. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T, Hunter JA, Capell HA.
    Br J Rheumatol; 1985 Aug 15; 24(3):269-76. PubMed ID: 2861876
    [Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis.
    Taggart AJ, McDermott B, Delargy M, Elborn S, Forbes J, Roberts SD, Ahnfelt NO.
    Scand J Rheumatol Suppl; 1987 Aug 15; 64():29-36. PubMed ID: 2893450
    [Abstract] [Full Text] [Related]

  • 9. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE, Amos RS.
    Ann Rheum Dis; 1985 Mar 15; 44(3):194-8. PubMed ID: 2858182
    [Abstract] [Full Text] [Related]

  • 10. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW.
    Drugs; 1985 Apr 15; 29(4):342-75. PubMed ID: 2859977
    [Abstract] [Full Text] [Related]

  • 11. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z, Vácha J, Trnavský K.
    Z Rheumatol; 1985 Apr 15; 44(6):263-6. PubMed ID: 2869625
    [Abstract] [Full Text] [Related]

  • 12. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH, van Riel PL, van de Putte LB, Gribnau FW.
    Ann Rheum Dis; 1989 May 15; 48(5):389-95. PubMed ID: 2567150
    [Abstract] [Full Text] [Related]

  • 13. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial.
    Faarvang KL, Egsmose C, Kryger P, Pødenphant J, Ingeman-Nielsen M, Hansen TM.
    Ann Rheum Dis; 1993 Oct 15; 52(10):711-5. PubMed ID: 7903034
    [Abstract] [Full Text] [Related]

  • 14. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis.
    Taggart AJ, McDermott BJ, Roberts SD.
    Clin Pharmacokinet; 1992 Oct 15; 23(4):311-20. PubMed ID: 1356683
    [Abstract] [Full Text] [Related]

  • 15. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC, Grindulis KA, Hubball S, McConkey B, Wright V.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1099-102. PubMed ID: 6138116
    [Abstract] [Full Text] [Related]

  • 16. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A, Pedone V, Lamanna G, Cervini C.
    Clin Ter; 1997 Oct 15; 148(1-2):7-13. PubMed ID: 9377840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.